In a 2008 study published in the journal Food Chemistry & Toxicology titled, "Comparative evaluation of the hypolipidemic effects of coconut water and lovastatin in rats fed fat-cholesterol enriched diet," the beverage coconut water was as effective as Merck's original cholesterol-lowering drug in positively modulating blood lipid levels in rats.
A recent study, published in the Archives of Internal Medicine, found that the cholesterol-lowering drugs known as statins increase the risk of diabetes within postmenopausal women by 48%.
This new finding adds to a growing body of clinical evidence that statin drugs are fundamentally diabetogenic, which is not surprising considering the National Library of Medicine contains peer-reviewed, published research on over 300 other known adverse effects associated with their use.
More and more women are being prescribed cholesterol-lowering statins and some doctors are even recommending the drugs be added to the water supply or dispensed at the McDonald’s drive-thru windows.
However, postmenopausal women using statins may be increasing their risk of diabetes according to a study published by the Archives of Internal Medicine.
